SCHEMBL6949029

SCHEMBL6949029

CN(CCc1ccncc1)S(=O)(=O)c1ccc2c(c1)C(Cl)(Cl)C(=O)N2

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PKLR P30613 1/20 0.42
CASP3 P42574 2/20 0.40
NAMPT P43490 1/20 0.39
HTT P42858 3/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 3/20 0.37
TDP1 Q9NUW8 2/20 0.37
MAPK1 P28482 2/20 0.37
TBXAS1 P24557 1/20 0.37
ATM Q13315 1/20 0.37
GAA P10253 1/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
PDE4D Q08499 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950459 0.81 KMT2A (0.48) PKLRCASP3NAMPTALDH1A1GAA
SCHEMBL7736087 0.80 CASP3 (0.64) CASP3NAMPTGAAMAOAMAOB
SCHEMBL8307133 0.79 CASP3 (0.63) PKLRCASP3LMNAALDH1A1GAA
SCHEMBL7804480 0.79 CASP3 (0.49) CASP3NAMPT
SCHEMBL6946269 0.78 PKLR (0.44) PKLRCASP3LMNAALDH1A1GAA
SCHEMBL2333739 0.74 TDP1 (0.60) NAMPTHTTLMNASMN1; SMN2ALDH1A1
SCHEMBL8307129 0.73 PKLR (0.50) PKLRHTTLMNASMN1; SMN2ALDH1A1
SCHEMBL8307006 0.72 PKLR (0.42) PKLRCASP3SMN1; SMN2ALDH1A1TDP1
SCHEMBL11174132 0.71 TDP1 (0.51) NAMPTHTTLMNASMN1; SMN2ALDH1A1
SCHEMBL30555219 0.68 PKLR (0.55) PKLRALDH1A1TDP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0988035-B1 CASPASES AND APOPTOSIS SMITHKLINE BEECHAM CORP (US) 2003-05-02 EP claimed
US-6214858-B1 PREVENTING AND TREATING EXCESSIVE CELL DEATH USING OXINDOLE DERIVATIVES SMITHKLINE BEECHAM CORPORATION 2001-04-10 US claimed
EP-0988035-B1 CASPASES AND APOPTOSIS SMITHKLINE BEECHAM CORP (US) 2003-05-02 EP disclosed
US-6214858-B1 PREVENTING AND TREATING EXCESSIVE CELL DEATH USING OXINDOLE DERIVATIVES SMITHKLINE BEECHAM CORPORATION 2001-04-10 US disclosed